Pito Chickering
Stock Analyst at Deutsche Bank
(4.56)
# 1,021
Out of 5,162 analysts
371
Total ratings
60.6%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Reiterated: Buy | $32 → $46 | $34.47 | +33.45% | 25 | Nov 9, 2026 | |
| BLCO Bausch + Lomb | Reiterated: Hold | $16 → $20 | $20.69 | -3.33% | 8 | Oct 29, 2026 | |
| BSX Boston Scientific | Reiterated: Buy | $60 → $48 | $42.99 | +11.65% | 19 | Oct 29, 2026 | |
| LH Labcorp Holdings | Reiterated: Hold | $306 → $355 | $368.88 | -3.76% | 15 | Oct 29, 2026 | |
| EHC Encompass Health | Reiterated: Buy | $95 → $142 | $132.28 | +7.35% | 16 | Sep 18, 2026 | |
| MDT Medtronic | Rated: Hold | $85 → $92 | $100.61 | -8.56% | 22 | Sep 3, 2026 | |
| MMED MiniMed Group | Rated: Buy | $20 → $25 | $16.26 | +53.75% | 2 | Sep 2, 2026 | |
| MDLN Medline | Rated: Hold | $42 → $37 | $37.84 | -2.22% | 4 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $107 → $98 | $101.47 | -3.42% | 18 | Aug 6, 2026 | |
| DVA DaVita | Rated: Buy | $220 → $265 | $156.34 | +69.50% | 22 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $19 → $25 | $29.94 | -16.50% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $70 | $64.02 | +9.34% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 → $27 | $25.39 | +6.34% | 16 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $24 | $31.61 | -24.07% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $441 → $476 | $460.33 | +3.40% | 21 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $402 → $315 | $313.08 | +0.61% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $7.25 | +31.03% | 18 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $14.06 | +56.47% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $12 | $10.70 | n/a | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $94 | $103.88 | n/a | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 → $178 | $259.09 | n/a | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.1716 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $205 → $241 | $320.01 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $174.98 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $263.59 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $62 | $17.59 | n/a | 1 | Apr 19, 2021 |
Acadia Healthcare Company
Nov 9, 2026
Reiterated: Buy
Price Target: $32 → $46
Current: $34.47
Upside: +33.45%
Bausch + Lomb
Oct 29, 2026
Reiterated: Hold
Price Target: $16 → $20
Current: $20.69
Upside: -3.33%
Boston Scientific
Oct 29, 2026
Reiterated: Buy
Price Target: $60 → $48
Current: $42.99
Upside: +11.65%
Labcorp Holdings
Oct 29, 2026
Reiterated: Hold
Price Target: $306 → $355
Current: $368.88
Upside: -3.76%
Encompass Health
Sep 18, 2026
Reiterated: Buy
Price Target: $95 → $142
Current: $132.28
Upside: +7.35%
Medtronic
Sep 3, 2026
Rated: Hold
Price Target: $85 → $92
Current: $100.61
Upside: -8.56%
MiniMed Group
Sep 2, 2026
Rated: Buy
Price Target: $20 → $25
Current: $16.26
Upside: +53.75%
Medline
Aug 6, 2026
Rated: Hold
Price Target: $42 → $37
Current: $37.84
Upside: -2.22%
Zimmer Biomet Holdings
Aug 6, 2026
Reiterated: Hold
Price Target: $107 → $98
Current: $101.47
Upside: -3.42%
DaVita
Aug 5, 2026
Rated: Buy
Price Target: $220 → $265
Current: $156.34
Upside: +69.50%
Aug 5, 2026
Rated: Hold
Price Target: $19 → $25
Current: $29.94
Upside: -16.50%
Aug 3, 2026
Rated: Buy
Price Target: $60 → $70
Current: $64.02
Upside: +9.34%
Jul 31, 2026
Reiterated: Hold
Price Target: $20 → $27
Current: $25.39
Upside: +6.34%
Jul 30, 2026
Downgraded: Hold
Price Target: $26 → $24
Current: $31.61
Upside: -24.07%
Jul 27, 2026
Rated: Buy
Price Target: $441 → $476
Current: $460.33
Upside: +3.40%
May 1, 2026
Reiterated: Hold
Price Target: $402 → $315
Current: $313.08
Upside: +0.61%
Feb 25, 2026
Reiterated: Hold
Price Target: $9.5
Current: $7.25
Upside: +31.03%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $14.06
Upside: +56.47%
Sep 15, 2025
Reiterated: Buy
Price Target: $7 → $12
Current: $10.70
Upside: n/a
Jul 25, 2025
Reiterated: Buy
Price Target: $85 → $94
Current: $103.88
Upside: n/a
Jul 23, 2025
Reiterated: Hold
Price Target: $136 → $178
Current: $259.09
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.1716
Upside: n/a
Oct 31, 2024
Reiterated: Buy
Price Target: $205 → $241
Current: $320.01
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $174.98
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $263.59
Upside: n/a
Apr 19, 2021
Reiterated: Hold
Price Target: $62
Current: $17.59
Upside: n/a